title: Zeroing in on Tumor-Reactive TILs.
abstract: Adoptive cell transfer of tumor-specific T cells provides an effective strategy for cancer immunotherapy. An article in this issue provides a novel approach to refine this technology by identifying tumor-reactive T cells based on frequency and PD-1 expression. Cancer Immunol Res; 4(9); 719. ©2016 AACRSee article by Ascierto et al., p. 726.
authors: Princess Margaret Cancer Centre, Ontario Cancer Institute, UHN, University of Toronto, Departments of Medical Biophysics and Immunology, Toronto, Canada. pohashi@uhnresearch.ca.
authors: Pamela S
authors: PS
authors: Ohashi
mesh_terms: D018414:CD8-Positive T-Lymphocytes; D006801:Humans; D016219:Immunotherapy, Adoptive; D016246:Lymphocytes, Tumor-Infiltrating; D009369:Neoplasms; D011948:Receptors, Antigen, T-Cell
chemical_list: D011948:Receptors, Antigen, T-Cell